Trial intelligence / Profile preview

Physostigmine as supportive adjunct to PCA after major surgery in ICU patients

2006-004349-41Phase 2Active

Sponsor
Universitätsmedizin Mannheim
Start
Sep 2006
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of physostigmine and piritramide in postoperative pain (2 arms), sponsored by Universitätsmedizin Mannheim. Primary endpoints: Pain intensity reduction and Opioid consumption. Started Sep 2006; status: active.

02

Drugs

physostigminepiritramide
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2006-004349-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004349-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call